HomeNews & TopicsResearchOrgan donations after MAiD made up 14 per cent of deceased donations...

Organ donations after MAiD made up 14 per cent of deceased donations in Quebec

Published on

Organ donation after medical assistance in dying (MAiD) represented 14 per cent of Quebec’s total deceased donations in 2022, according to a new study in CMAJ (Canadian Medical Association Journal).

To understand the impact of organ donation after MAiD, Quebec researchers analyzed data on all patients referred to Transplant Québec for possible organ donation after MAiD from January 2018 to December 2022. This represented the first 5 full years when organ donation after MAiD was allowed in the province. Over the 5-year period, Transplant Québec received 245 referrals for donation after MAiD, with an increase in annual referrals from 21 in 2018 to 109 in 2022. The total number of donor patients after MAiD was 64, increasing from eight in 2018 to 24 in 2022. Donations after MAiD represented 14 per cent of all deceased organ donations in 2022, and the majority of the donors had neurodegenerative diseases, with amyotrophic lateral sclerosis the most common condition. The average age of donors after MAiD was 60 years, and 64% were male.

“Our analysis of data related to organ donation after MAiD in Quebec shows that organ donation organizations can establish systems that honour the wishes of patients pursuing MAiD to donate their organs after their death,” writes Dr. Matthew Weiss, a pediatric critical care physician at Centre Mère-Enfant Soleil du CHU de Québec, Quebec, and medical director at Transplant Québec, with coauthors. “However, much remains to be learned regarding how to optimize the system to ensure that donation requests are treated in the most ethical and medically effective way.”

The authors note that it is not known how many patients were offered the choice to donate after MAiD or what the consent rate is in that group, as there is currently no system to track this information.

“Patients considering MAiD are among the most vulnerable patients in the health care system, as they have intractable diseases that cause them immense suffering. The desire of some patients to help others after their death must be honoured, but in doing so, donation professionals must assure the system respects their autonomy and dignity,” the authors conclude.

Organ donation after medical assistance in dying: a descriptive study from 2018 to 2022 in Quebec” was published January 29, 2024.

Related articles:

MAiD is not driven by socioeconomic vulnerability or poor access to palliative care

UHN physician helping create standardized curriculum for MAID program across Canada

Should medical assistance in dying be reported to the Coroner?

 

Latest articles

Still managing fax referrals manually?

Despite decades of digital transformation initiatives, one technology still dominates referral intake across hospitals...

New research links brain region to linguistic ability

The cerebellum, typically associated with movement, may also play a key role in reading...

Making Clinical Research a Care Option: How Digital Infrastructure is Expanding Access to Clinical Trials in Canada

Across Canada, there is growing recognition that clinical research should not be viewed as...

Privacy-First AI: How Federated Learning Is Transforming Canadian Cancer Research

Imagine training an AI model on patient data from hospitals in Vancouver, Toronto, and...

More like this

This Canadian startup is decoding the health data revealed in our eyes

If you’ve had a fluorescein angiography (FA), chances are you remember it. The procedure...

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...